Loading
Latest filing published 30 Jun 2026 for Kymera Therapeutics, Inc., €7.4M.
No signal scores available.
Only one filing by Bruce N. Jacobs is known so far (30 June 2026): a transaction, €7.4M, in Kymera Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration